Cardiovascular Agent
Antiphospholipid antibodies increase risk for future cardiovascular disease in lupus
SAN DIEGO — Patients with systemic lupus erythematosus who are positive for antiphospholipid antibodies have a greater risk for future atherosclerotic cardiovascular disease, according to data presented at ACR Convergence 2023.
Seizures associated with earlier decline to MCI in cognitively healthy adults
ORLANDO — In cognitively healthy adults, the presence of seizures predicted earlier change from normal cognition to mild cognitive impairment but was not associated with change from MCI to dementia. according to research.
Nonalcoholic fatty liver disease linked to increased risk for dementia
Patients with nonalcoholic fatty liver disease had an increased risk for dementia, with stronger risk existing for those with comorbid heart disease or stroke, according to a study published in Neurology.
Long-term cardiovascular risk trajectory predicts cognitive decline, dementia
Cumulative cardiovascular risk is a significant factor in determining the risk for cognitive decline and dementia, according to a study published in Neurology.
Part of the Healio Network
Pill in the Pocket
Flecainide can be used with a “pill-in-the-pocket” approach. If documented to be successful and safe while hospitalized, flecainide can be used on an as-needed basis in the outpatient setting.